Empaglin Met Extended-Release Tablet 12.5/1000 mg (Empagliflozin, Metformin Hydrochloride)

Adult dose

The dosage of this medication should be determined within the recommended maximum daily doses of 25 mg of empagliflozin and 2000 mg of extended-release metformin hydrochloride, taking into account each patient's current treatment, efficacy, and tolerance. This medication is taken once daily in the evening with meals to reduce gastrointestinal side effects caused by metformin. For this medication 10/1000 mg extended-release tablet or 25/1000 mg extended-release tablet,

This medication is used to treat diabetes and helps lower blood sugar. However, it may rarely cause a serious condition called lactic acidosis, so caution is necessary. When used with other diabetes medications, the risk of hypoglycemia may increase, so care should be taken. Patients with moderate to severe renal impairment, acute kidney problems, heart failure, severe infections, or those scheduled for surgery should not use this medication. In addition, pregnant women and individuals with certain genetic disorders should not be administered this drug. During treatment with this medication, regular kidney function tests are advised, and patients should consult their physician immediately if conditions such as dehydration, severe vomiting, or diarrhea occur. Symptoms of hypoglycemia may appear, and dosage adjustments may be necessary when used in conjunction with insulin or other hypoglycemic agents. Urinary or genital infections may occur; thus, prompt treatment should be sought if symptoms of infection arise. Caution should be exercised when using this medication in patients with liver dysfunction, and it is advisable to avoid alcohol consumption. Prior to surgery or examinations using iodinated contrast agents, temporarily discontinue this medication, and ensure normal kidney function afterwards. It is safest not to use this drug during pregnancy or breastfeeding. Elderly patients or those with poor nutritional status should use this medication with particular caution, and in case of overdose, immediate treatment at a hospital is required. This medication should be swallowed whole without crushing, chewing, or splitting; the tablet shell may appear in the stool, which is normal.

Serious side effects

Urticaria, angioedema, necrosis of the perineum, ketoacidosis, lactic acidosis, pyelonephritis, urosepsis, hepatitis, liver dysfunction (jaundice), liver impairment, severe allergic reactions, severe skin adverse reactions, sudden and severe headache, lightning headache, seizures, consciousness confusion, visual disturbances, paralysis, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, markedly decreased urine output, generalized severe edema,

Mild side effects

• Hypoglycemia
• urinary tract infections
• genital infections
• increased urination
• nausea
• vomiting
• diarrhea
• abdominal pain
• loss of appetite
• constipation

This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. Additionally, avoid storage in excessively hot or cold places and maintain a temperature between 1 to 30 degrees Celsius at room temperature.

Appearance

Brown, oval-shaped, bilaterally convex extended-release film-coated tablet

Package unit

30 tablets/bottle